Harm Arentsen Urologie SRL
Harm Arentsen Urologie reported total assets of €1.85m at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
The score of Harm Arentsen Urologie shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +118 % Total assets +97 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Harm Arentsen Urologie's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 01 Sep 2023
- Year ended 31 Dec 2021filed on 25 Aug 2022
Harm Arentsen Urologie's financial analysis
- Solvency99.2%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Harm Arentsen Urologie
Harm Arentsen Urologie's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0666.918.946
- VAT number
- BE0666918946
- Peppol
- Registered · 0208:0666918946 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 02 Dec 2016
- Registered office
- 8200 Bruges
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Medical specialists activities (NACE 86220)
Harm Arentsen Urologie (SRL) has been based in Bruges since 2016, active in: medical specialists activities. For 2025, it reports a net profit of 417,171 € and equity of €1.84m; its revenue is not published. Its solvency stands at 99.2%, above the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Harm Arentsen Urologie
Companies in the same business, of comparable size and area, outside its group.
- Dokter Mollet Peter Medical specialists activities Jabbeke · balance sheet €2.00m
- Dr. Matthias Desmet - Dr. Sofie Decock Medical specialists activities Bruges · balance sheet €2.28m
- Dr. Iris Deruytter Medical specialists activities Bruges · balance sheet €1.47m
- Dr. N. Walgraeve Medical specialists activities Jabbeke · balance sheet €1.45m
- Docteur Cyrille Degauque Medical specialists activities Verviers · balance sheet 143,682 €
- Dr. Piet Dekimpe Medical specialists activities Bruges · balance sheet €1.42m
- Geriaters AZ Delta Medical specialists activities Roeselare · balance sheet €1.10m
- Artsen Radiologie AZ Delta Medical specialists activities Roeselare · balance sheet €4.35m
Frequently asked questions about Harm Arentsen Urologie
What is the revenue of Harm Arentsen Urologie?
Harm Arentsen Urologie files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Harm Arentsen Urologie?
In Belgium, the VAT number is the company number prefixed with BE: BE0666918946 for Harm Arentsen Urologie, if the company is VAT-registered. Its company number (CBE) is 0666.918.946.
Where is the registered office of Harm Arentsen Urologie?
According to the CBE register, the registered office of Harm Arentsen Urologie is in 8200 Bruges.
What is the equity of Harm Arentsen Urologie?
At the close of the 2025 financial year, the equity of Harm Arentsen Urologie amounts to 1,835,698 €, a solvency of 99.2% of total assets.
Who manages Harm Arentsen Urologie?
The register lists 1 active mandates at Harm Arentsen Urologie. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Harm Arentsen Urologie
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →